BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3131074)

  • 1. Antiparasitic effects of tumour necrosis factor in vivo and in vitro.
    Playfair JH; Taverne J
    Ciba Found Symp; 1987; 131():192-205. PubMed ID: 3131074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.
    Taverne J; Tavernier J; Fiers W; Playfair JH
    Clin Exp Immunol; 1987 Jan; 67(1):1-4. PubMed ID: 3621669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.
    Clark IA; Hunt NH; Butcher GA; Cowden WB
    J Immunol; 1987 Nov; 139(10):3493-6. PubMed ID: 3119710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients.
    Karunaweera ND; Carter R; Grau GE; Kwiatkowski D; Del Giudice G; Mendis KN
    Clin Exp Immunol; 1992 Jun; 88(3):499-505. PubMed ID: 1351432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.
    Taverne J; Matthews N; Depledge P; Playfair JH
    Clin Exp Immunol; 1984 Aug; 57(2):293-300. PubMed ID: 6467675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected problems of malaria blood stage immunity.
    Perlmann P; Perlmann H; Berzins K; Troye-Blomberg M
    Tokai J Exp Clin Med; 1998 Apr; 23(2):55-62. PubMed ID: 10021776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor and associated cytokines in the host's response to malaria.
    Richards AL
    Int J Parasitol; 1997 Oct; 27(10):1251-63. PubMed ID: 9394195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential.
    Naotunne TS; Karunaweera ND; Del Giudice G; Kularatne MU; Grau GE; Carter R; Mendis KN
    J Exp Med; 1991 Mar; 173(3):523-9. PubMed ID: 1900073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of inducers of crisis forms in Plasmodium falciparum in vitro.
    Carlin JM; Jensen JB; Geary TG
    Am J Trop Med Hyg; 1985 Jul; 34(4):668-74. PubMed ID: 3927759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killing of Plasmodium falciparum by human monocyte-derived macrophages.
    Jones KR; Cottrell BJ; Targett GA; Playfair JH
    Parasite Immunol; 1989 Nov; 11(6):585-92. PubMed ID: 2515516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages.
    Ockenhouse CF; Schulman S; Shear HL
    J Immunol; 1984 Sep; 133(3):1601-8. PubMed ID: 6431003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor necrosis serum induce Plasmodium falciparum crisis form].
    Yao YM; Hou GP; Wang MY; Cui ZR; Cai FQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1990; 8(4):302-4. PubMed ID: 2099264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-parasite effects of cytokines in malaria.
    Mendis KN; Naotunne TD; Karunaweera ND; Del Giudice G; Grau GE; Carter R
    Immunol Lett; 1990 Aug; 25(1-3):217-20. PubMed ID: 2126526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity.
    Golden JM; Tarleton RL
    Exp Parasitol; 1991 May; 72(4):391-402. PubMed ID: 1902795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.
    Oswald IP; Wynn TA; Sher A; James SL
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8676-80. PubMed ID: 1528880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF and inhibition of growth of Plasmodium falciparum.
    Clark IA; Cowden WB; Butcher GA
    Immunol Lett; 1990 Aug; 25(1-3):175-8. PubMed ID: 2283147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interferon-gamma and tumor necrosis factor in host resistance to Plasmodium chabaudi AS.
    Stevenson MM; Tam MF; Nowotarski M
    Immunol Lett; 1990 Aug; 25(1-3):115-21. PubMed ID: 2126523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.
    Havell EA; Fiers W; North RJ
    J Exp Med; 1988 Mar; 167(3):1067-85. PubMed ID: 3351434
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.